HOWL
Price
$1.02
Change
-$0.18 (-15.00%)
Updated
Jun 27 closing price
Capitalization
46.89M
40 days until earnings call
PHVS
Price
$17.00
Change
-$0.90 (-5.03%)
Updated
Jun 27 closing price
Capitalization
924.75M
27 days until earnings call
Interact to see
Advertisement

HOWL vs PHVS

Header iconHOWL vs PHVS Comparison
Open Charts HOWL vs PHVSBanner chart's image
Werewolf Therapeutics
Price$1.02
Change-$0.18 (-15.00%)
Volume$4.23M
Capitalization46.89M
Pharvaris
Price$17.00
Change-$0.90 (-5.03%)
Volume$33.52K
Capitalization924.75M
HOWL vs PHVS Comparison Chart in %
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. PHVS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Hold and PHVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (HOWL: $1.04 vs. PHVS: $16.97)
Brand notoriety: HOWL and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 606% vs. PHVS: 43%
Market capitalization -- HOWL: $46.89M vs. PHVS: $924.75M
HOWL [@Biotechnology] is valued at $46.89M. PHVS’s [@Biotechnology] market capitalization is $924.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 4 TA indicator(s) are bullish while PHVS’s TA Score has 5 bullish TA indicator(s).

  • HOWL’s TA Score: 4 bullish, 5 bearish.
  • PHVS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than HOWL.

Price Growth

HOWL (@Biotechnology) experienced а -12.18% price change this week, while PHVS (@Biotechnology) price change was +1.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

HOWL is expected to report earnings on Aug 07, 2025.

PHVS is expected to report earnings on Jul 25, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($925M) has a higher market cap than HOWL($46.9M). PHVS YTD gains are higher at: -11.476 vs. HOWL (-29.392). HOWL has higher annual earnings (EBITDA): -65.72M vs. PHVS (-159.25M). PHVS has more cash in the bank: 236M vs. HOWL (92M). PHVS has less debt than HOWL: PHVS (741K) vs HOWL (37M). HOWL has higher revenues than PHVS: HOWL (1.14M) vs PHVS (0).
HOWLPHVSHOWL / PHVS
Capitalization46.9M925M5%
EBITDA-65.72M-159.25M41%
Gain YTD-29.392-11.476256%
P/E RatioN/AN/A-
Revenue1.14M0-
Total Cash92M236M39%
Total Debt37M741K4,993%
TECHNICAL ANALYSIS
Technical Analysis
HOWLPHVS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend about 1 month ago
80%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 24 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMCFX10.590.01
+0.09%
Royce Micro-Cap Svc
EGFIX46.57N/A
N/A
Edgewood Growth Instl
GFVCX15.25N/A
N/A
Goldman Sachs Focused Value C
TCMHX22.51N/A
N/A
Nuveen Quant Mid Cap Growth I
ACIZX51.56N/A
N/A
Alger Capital Appreciation Instl Z-2

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with IPSC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-12.55%
IPSC - HOWL
44%
Loosely correlated
-5.74%
GBIO - HOWL
44%
Loosely correlated
-5.63%
ARCT - HOWL
43%
Loosely correlated
-7.56%
CLDX - HOWL
42%
Loosely correlated
-4.16%
ABOS - HOWL
41%
Loosely correlated
-5.37%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with ATXS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-5.20%
ATXS - PHVS
36%
Loosely correlated
+2.94%
SYRE - PHVS
33%
Loosely correlated
-4.99%
HOWL - PHVS
33%
Loosely correlated
-12.55%
MGTX - PHVS
33%
Poorly correlated
-0.45%
COGT - PHVS
33%
Poorly correlated
-3.07%
More